AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery.
Find out more about Labgenius here and follow them on LinkedIn